Clinical Trials Browser

Phase 3 × Completed × Eflornithine × Clear all

NCT01483144 2021-06-08

Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)

Phase 3 Completed

171 enrolled 13 charts

Gastrointestinal

Adenomatous Polyposis Coli

NCT00118365 2015-01-22

Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps

Phase 3 Completed

375 enrolled 27 charts

Precancerous Conditions

NCT00003814 2013-12-18

Eflornithine in Treating Patients With Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms